Skip to main content

Table 1 Patients demographic and perioperative data

From: Surgical treatment on infective endocarditis: impact of diabetes on mortality

 

Group I (Not-DM patients)

Group II (DM patients)

p Value

N

326

94

 

Age (years)

54.8 ± 16.1

66.4 ± 11.1

0.000

Male gender (n, %)

214 (65.6%)

61 (64.9%)

0.902

NIHA III-IV (n, %)

103 (31.6%)

37 (39.4%)

0.234

Previous cardiac surgery (n, %)

124 (38.0%)

36 (38.3%)

1.000

Native valve endocarditis (n, %)

212 (65.0%)

62 (66.0%)

0.903

EF (%)

54.6 ± 15.1

54.8 ± 15.9

0.914

Hypertension (n, %)

136 (42.0%)

76 (81.7%)

0.000

COPD (n, %)

15 (4.6%)

10 (10.8%)

0.044

Dialysis (n, %)

6 (2.1%)

5 (6.5%)

0.057

Hyperlipidemia (n, %)

100 (31.0%)

77 (81.9%)

0.000

PVD (n, %)

7 (2.2%)

12 (13.5%)

0.000

CVA/TIA (n, %)

46 (14.7%)

17 (18.5%)

0.414

Pulmonary hypertension (n, %)

40 (12.9%)

13(14.6%)

0.723

Smoking (n, %)

81 (25.3%)

35 (38.5%)

0.017

Standard EuroSCORE I

7.4 ± 3.9

10.0 ± 4.1

0.000

Logistic EuroSCORE %

16.3 ± 17.7

27.3 ± 24.4

0.000

Bypass time (min)

121.7 ± 56.1

148.8 ± 68.1

0.001

Cross-clamp (min)

86.1 ± 37.6

108.5 ± 48.3

0.000

Aortic valve involvement (n, %)

172 (52.8%)

55 (58.5%)

0.349

Mitral valve involvement (n, %)

175 (53.7%)

54 (57.4%)

0.558

Tricuspid valve involvement (n, %)

2 (0.6%)

0 (0%)

0.280

Annular reconstruction (n, %)

44 (13.5%)

21 (22.3%)

0.023

Concomitant procedure (n, %)

128 (39.3%)

54 (57.4%)

0.434